Q3 Earnings Estimate for AptarGroup Issued By Zacks Research

AptarGroup, Inc. (NYSE:ATR) – Analysts at Zacks Research upped their Q3 2026 EPS estimates for shares of AptarGroup in a research note issued to investors on Tuesday, September 29th. Zacks Research analyst Team now anticipates that the industrial products company will post earnings per share of $1.46 for the quarter, up from their prior forecast of $1.45. The consensus estimate for AptarGroup’s current full-year earnings is $5.48 per share. Zacks Research also issued estimates for AptarGroup’s FY2026 earnings at $5.46 EPS, Q1 2027 earnings at $1.34 EPS, Q2 2027 earnings at $1.53 EPS, FY2027 earnings at $5.90 EPS, Q1 2028 earnings at $1.64 EPS and Q2 2028 earnings at $1.67 EPS.

AptarGroup (NYSE:ATR) last announced its quarterly earnings data on Thursday, July 30th. The industrial products company reported $1.42 earnings per share for the quarter, topping analysts’ consensus estimates of $1.35 by $0.07. AptarGroup had a net margin of 9.22% and a return on equity of 13.31%. The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1.01 billion. During the same quarter in the prior year, the company earned $1.66 earnings per share. The business’s revenue was up 6.3% compared to the same quarter last year. AptarGroup has set its Q3 2026 guidance at 1.450-1.530 EPS.

Other equities research analysts have also recently issued reports about the company. Bank of America raised AptarGroup from a “neutral” rating to a “buy” rating and set a $173.00 target price on the stock in a research note on Tuesday, July 14th. Raymond James Financial reaffirmed an “outperform” rating and issued a $160.00 price target on shares of AptarGroup in a research report on Wednesday, July 15th. Weiss Ratings reiterated a “hold (c)” rating on shares of AptarGroup in a research note on Monday, September 21st. Finally, Wells Fargo & Company increased their price objective on shares of AptarGroup from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Five analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $172.80.

AptarGroup Stock Down 0.3%

Shares of NYSE:ATR opened at $120.81 on Wednesday. The company has a current ratio of 1.61, a quick ratio of 1.10 and a debt-to-equity ratio of 0.42. The stock has a fifty day simple moving average of $129.87 and a two-hundred day simple moving average of $125.47. AptarGroup has a 12-month low of $103.23 and a 12-month high of $146.91. The stock has a market capitalization of $7.68 billion, a price-to-earnings ratio of 21.85, a PEG ratio of 3.09 and a beta of 0.34.

AptarGroup Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 20th. Investors of record on Thursday, July 30th were issued a $0.48 dividend. The ex-dividend date was Thursday, July 30th. This represents a $1.92 annualized dividend and a yield of 1.6%. AptarGroup’s dividend payout ratio (DPR) is currently 34.72%.

Insider Activity at AptarGroup

In other AptarGroup news, insider Hedi Tlili sold 8,854 shares of AptarGroup stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $135.00, for a total value of $1,195,290.00. Following the completion of the sale, the insider owned 15,379 shares of the company’s stock, valued at approximately $2,076,165. The trade was a 36.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Gael Touya sold 3,740 shares of the business’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $133.76, for a total transaction of $500,262.40. Following the sale, the chief executive officer owned 29,102 shares of the company’s stock, valued at approximately $3,892,683.52. This represents a 11.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 23,197 shares of company stock worth $3,134,828. Company insiders own 0.73% of the company’s stock.

Institutional Trading of AptarGroup

A number of hedge funds have recently bought and sold shares of ATR. Rothschild Investment LLC raised its position in AptarGroup by 231.1% in the fourth quarter. Rothschild Investment LLC now owns 202 shares of the industrial products company’s stock worth $25,000 after acquiring an additional 141 shares during the period. Geneos Wealth Management Inc. increased its stake in shares of AptarGroup by 214.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 201 shares of the industrial products company’s stock worth $25,000 after purchasing an additional 137 shares in the last quarter. Silvant Capital Management LLC bought a new position in AptarGroup in the 2nd quarter worth $30,000. Whittier Trust Co. raised its holdings in AptarGroup by 169.5% in the 1st quarter. Whittier Trust Co. now owns 283 shares of the industrial products company’s stock worth $36,000 after purchasing an additional 178 shares during the period. Finally, Parkside Financial Bank & Trust lifted its position in AptarGroup by 41.9% during the second quarter. Parkside Financial Bank & Trust now owns 298 shares of the industrial products company’s stock valued at $37,000 after purchasing an additional 88 shares in the last quarter. Hedge funds and other institutional investors own 88.52% of the company’s stock.

About AptarGroup

AptarGroup, Inc (NYSE: ATR) is a global company that designs and manufactures dispensing, drug-delivery and packaging solutions. Its products are used by pharmaceutical, consumer health, beauty, personal care, food and beverage companies, helping customers deliver, protect and package a wide range of products.

The company operates through three primary businesses: Aptar Pharma, which develops delivery systems for nasal, inhaled, ophthalmic and other drug applications; Aptar Beauty, which supplies dispensing systems, pumps, sprayers and packaging components for beauty and personal care products; and Aptar Closures, which produces dispensing closures and other packaging systems for food, beverage, personal care and household products.

Aptar serves customers internationally through manufacturing, research and development, and commercial operations across North America, Europe, Asia and other global markets.